Brief: Senti Biosciences Q2 Net Income USD -14.733 Million
07/08/2025 13:05
Aug 07 (Reuters) - Senti Biosciences Q2 operating income USD -16.798 million. Q2 operating expenses USD 16.798 million Q2 EPS USD -0.56
Recent news on Senti Biosciences Holdings
See all newsBrief: Senti Biosciences Says Offering 15.97 Million Shares Of Common Stock For Resale By Selling Securityholder
Senti Biosciences Q1 net loss narrows on cost reduction
Brief: Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy
Brief: Senti Biosciences Announces Holding Company Reorganization Effective By April 16, 2026 - SEC Filing
Senti Biosciences Q4 revenue misses analyst estimates